984 related articles for article (PubMed ID: 17958624)
21. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
22. Incidence and prognostic significance of skin disease in patients with HIV/AIDS: a 5-year observational study.
Jensen BL; Weismann K; Sindrup JH; Søndergaard J; Schmidt K
Acta Derm Venereol; 2000; 80(2):140-3. PubMed ID: 10877138
[TBL] [Abstract][Full Text] [Related]
23. Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World.
Lindoso JA; Barbosa RN; Posada-Vergara MP; Duarte MI; Oyafuso LK; Amato VS; Goto H
Br J Dermatol; 2009 Feb; 160(2):311-8. PubMed ID: 19187345
[TBL] [Abstract][Full Text] [Related]
24. Should absolute lymphocyte count be used as a surrogate marker for CD4+ count in patients with HIV/AIDS?
Jibrin YB; Yusuph H; Garbati MA; Gashau W; Abja UM
Afr J Med Med Sci; 2006 Mar; 35(1):9-13. PubMed ID: 17209321
[TBL] [Abstract][Full Text] [Related]
25. [Epidemiology of skin diseases in HIV-infected patients: a prospective cohort study].
Schaub N; Gilli L; Rufli T; Gyr N; Battegay M; Nüesch R; Itin P
Praxis (Bern 1994); 1996 Sep; 85(38):1162-6. PubMed ID: 8927894
[TBL] [Abstract][Full Text] [Related]
26. Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count.
Mañas E; Pulido F; Peña JM; Rubio R; Gonzalez-García J; Costa R; Pérez-Rodríguez E; Del Palacio A
Int J Tuberc Lung Dis; 2004 Apr; 8(4):451-7. PubMed ID: 15141738
[TBL] [Abstract][Full Text] [Related]
27. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.
Badri M; Ehrlich R; Wood R; Pulerwitz T; Maartens G
Int J Tuberc Lung Dis; 2001 Mar; 5(3):225-32. PubMed ID: 11326821
[TBL] [Abstract][Full Text] [Related]
28. [Mucocutaneous pathology in HIV infection].
Lamarão P; Eliseu T; Castro H; Maltez F; Machado J; Morgado A; Proença R
Acta Med Port; 1994 Mar; 7(3):141-8. PubMed ID: 7911640
[TBL] [Abstract][Full Text] [Related]
29. A preliminary study of the frequency of focal neurological deficits in HIV/AIDS patients seropositive for Toxoplasma gondii IgG in Lagos, Nigeria.
Oshinaike OO; Okubadejo NU; Ojini FI; Danesi MA
Nig Q J Hosp Med; 2010; 20(3):104-7. PubMed ID: 21033315
[TBL] [Abstract][Full Text] [Related]
30. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
[TBL] [Abstract][Full Text] [Related]
31. Histopathological study of cutaneous manifestations in HIV and AIDS patients.
Rane SR; Agrawal PB; Kadgi NV; Jadhav MV; Puranik SC
Int J Dermatol; 2014 Jun; 53(6):746-51. PubMed ID: 24320966
[TBL] [Abstract][Full Text] [Related]
32. Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile.
Tositti G; Rassu M; Fabris P; Giordani M; Cazzavillan S; Reatto P; Zoppelletto M; Bonoldi M; Baldo V; Manfrin V; de Lalla F
HIV Med; 2005 Jan; 6(1):27-32. PubMed ID: 15670249
[TBL] [Abstract][Full Text] [Related]
33. Cytokine profile in human immunodeficiency virus positive patients with and without tuberculosis.
Agarwal SK; Singh A; Anuradha S; Singh NP; Sokhi J; Baveja UK
J Assoc Physicians India; 2001 Aug; 49():799-802. PubMed ID: 11837467
[TBL] [Abstract][Full Text] [Related]
34. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.
Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H
Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175
[TBL] [Abstract][Full Text] [Related]
35. Study of prevalence, severity, and etiological factors associated with acute pancreatitis in patients infected with human immunodeficiency virus.
Dutta SK; Ting CD; Lai LL
Am J Gastroenterol; 1997 Nov; 92(11):2044-8. PubMed ID: 9362189
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.
Stebbing J; Sawleshwarkar S; Michailidis C; Jones R; Bower M; Mandalia S; Nelson M; Gazzard B
Postgrad Med J; 2005 Sep; 81(959):586-8. PubMed ID: 16143689
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between T-subsets and clinical aspects of HIV-associated diseases].
Fuchs M; Stadler BM; Malinverni R; de Weck AL; Pichler WJ
Schweiz Med Wochenschr; 1991 Jan; 121(3):57-66. PubMed ID: 1671535
[TBL] [Abstract][Full Text] [Related]
38. Oral lesions in HIV-positive patients in Georgia.
Kakabadze T; Rukhadze N; Mshvidobadze K; Lomtadze M; Kandelaki G
Georgian Med News; 2008 Dec; (165):60-5. PubMed ID: 19124919
[TBL] [Abstract][Full Text] [Related]
39. Correlation of clinical and laboratory surrogate markers of immunodepletion with T cell subsets (CD4 & CD8) determined flow cytometrically in HIV infected patients: a hospital based study.
Uppal SS; Gupta S; Verma S
J Commun Dis; 2003 Sep; 35(3):140-53. PubMed ID: 15796406
[TBL] [Abstract][Full Text] [Related]
40. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
